These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23347564

  • 1. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions.
    Prabowo AS, Iyer AM, Anink JJ, Spliet WG, van Rijen PC, Aronica E.
    J Neuroinflammation; 2013 Jan 24; 10():12. PubMed ID: 23347564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 24; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 4. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec 24; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ.
    Histol Histopathol; 2024 Sep 24; 39(9):1179-1195. PubMed ID: 38293776
    [Abstract] [Full Text] [Related]

  • 6. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 24; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van Rijen PC, Troost D, Gorter JA, Aronica E.
    Neuroscience; 2010 May 19; 167(3):929-45. PubMed ID: 20219643
    [Abstract] [Full Text] [Related]

  • 9. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar 19; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development.
    Aronica E, Ozbas-Gerçeker F, Redeker S, Ramkema M, Spliet WG, van Rijen PC, Leenstra S, Gorter JA, Troost D.
    Acta Neuropathol; 2004 Nov 19; 108(5):422-34. PubMed ID: 15375667
    [Abstract] [Full Text] [Related]

  • 14. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S, Piao Y, Fu Y, Li Z, Liu C, Lu D.
    Zhonghua Bing Li Xue Za Zhi; 2015 May 19; 44(5):305-9. PubMed ID: 26178210
    [Abstract] [Full Text] [Related]

  • 15. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 May 19; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, Baayen JC, Hol EM, Aronica E.
    Epilepsy Res; 2010 Jun 19; 90(1-2):99-109. PubMed ID: 20430588
    [Abstract] [Full Text] [Related]

  • 17. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov 19; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J, Broekaart DW, Scholl T, Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T, Hainfellner JA, Feucht M, Mühlebner A, van Vliet EA, Aronica E.
    J Neuroinflammation; 2016 Aug 26; 13(1):202. PubMed ID: 27566410
    [Abstract] [Full Text] [Related]

  • 19. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
    Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S.
    Acta Neuropathol; 2002 Oct 26; 104(4):418-24. PubMed ID: 12200630
    [Abstract] [Full Text] [Related]

  • 20. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun 26; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.